vs
ASURE SOFTWARE INC（ASUR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ASURE SOFTWARE INC的1.9倍（$69.8M vs $36.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -14.8%，领先398.8%），ASURE SOFTWARE INC同比增速更快（23.7% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 11.2%）
Asure Software是一家软件企业，其前身为Forgent Networks，2007年9月完成品牌更名后，业务逐渐拓展至人力资本管理领域，为客户提供薪资发放、考勤管理、人才管理、人力资源管理、福利管理以及保险相关服务等解决方案。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ASUR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.9倍
$36.3M
营收增速更快
ASUR
高出2.5%
21.2%
净利率更高
RIGL
高出398.8%
-14.8%
两年增速更快
RIGL
近两年复合增速
11.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.3M | $69.8M |
| 净利润 | $-5.4M | $268.1M |
| 毛利率 | 63.8% | 91.5% |
| 营业利润率 | -9.7% | 33.2% |
| 净利率 | -14.8% | 384.0% |
| 营收同比 | 23.7% | 21.2% |
| 净利润同比 | -37.5% | 1769.2% |
| 每股收益（稀释后） | $-0.19 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASURRIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $36.3M | $69.5M | ||
| Q2 25 | $30.1M | $101.7M | ||
| Q1 25 | $34.9M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | $29.3M | $55.3M | ||
| Q2 24 | $28.0M | $36.8M | ||
| Q1 24 | $31.7M | $29.5M |
净利润ASURRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-5.4M | $27.9M | ||
| Q2 25 | $-6.1M | $59.6M | ||
| Q1 25 | $-2.4M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-3.9M | $12.4M | ||
| Q2 24 | $-4.4M | $-1.0M | ||
| Q1 24 | $-308.0K | $-8.2M |
毛利率ASURRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | 63.8% | 93.2% | ||
| Q2 25 | 66.1% | 95.6% | ||
| Q1 25 | 70.6% | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | 67.2% | 85.5% | ||
| Q2 24 | 67.3% | 92.4% | ||
| Q1 24 | 71.4% | 93.1% |
营业利润率ASURRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | -9.7% | 40.9% | ||
| Q2 25 | -15.4% | 60.1% | ||
| Q1 25 | -5.8% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | -12.4% | 25.4% | ||
| Q2 24 | -14.9% | 1.2% | ||
| Q1 24 | -1.4% | -23.6% |
净利率ASURRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -14.8% | 40.2% | ||
| Q2 25 | -20.3% | 58.6% | ||
| Q1 25 | -6.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -13.3% | 22.5% | ||
| Q2 24 | -15.5% | -2.8% | ||
| Q1 24 | -1.0% | -27.9% |
每股收益（稀释后）ASURRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $-0.19 | $1.46 | ||
| Q2 25 | $-0.22 | $3.28 | ||
| Q1 25 | $-0.09 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | $-0.15 | $0.70 | ||
| Q2 24 | $-0.17 | $-0.06 | ||
| Q1 24 | $-0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.5M | $155.0M |
| 总债务越低越好 | $70.4M | $52.5M |
| 股东权益账面价值 | $193.1M | $391.5M |
| 总资产 | $447.1M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.36× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ASURRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | $21.5M | $137.1M | ||
| Q2 25 | $66.0M | $108.4M | ||
| Q1 25 | $14.1M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | $11.2M | $61.1M | ||
| Q2 24 | $20.7M | $49.1M | ||
| Q1 24 | $23.2M | $49.5M |
总债务ASURRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | $70.4M | $60.0M | ||
| Q2 25 | $67.4M | $60.0M | ||
| Q1 25 | $14.1M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | $7.5M | $60.0M | ||
| Q2 24 | $6.0M | $60.0M | ||
| Q1 24 | $5.3M | $60.0M |
股东权益ASURRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $193.1M | $117.6M | ||
| Q2 25 | $194.3M | $81.9M | ||
| Q1 25 | $197.7M | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $199.2M | $-14.6M | ||
| Q2 24 | $195.5M | $-29.9M | ||
| Q1 24 | $197.7M | $-31.7M |
总资产ASURRIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $447.1M | $242.5M | ||
| Q2 25 | $505.6M | $206.7M | ||
| Q1 25 | $498.9M | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | $428.1M | $139.4M | ||
| Q2 24 | $420.1M | $128.4M | ||
| Q1 24 | $469.3M | $126.5M |
负债/权益比ASURRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.36× | 0.51× | ||
| Q2 25 | 0.35× | 0.73× | ||
| Q1 25 | 0.07× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | — |
| 自由现金流率自由现金流/营收 | 15.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $11.6M | — |
8季度趋势，按日历期对齐
经营现金流ASURRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $5.8M | $24.0M | ||
| Q2 25 | $3.2M | $30.5M | ||
| Q1 25 | $2.0M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | $1.3M | $21.7M | ||
| Q2 24 | $2.2M | $302.0K | ||
| Q1 24 | $-3.9M | $-5.0M |
自由现金流ASURRIGL
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | $-4.2M | — |
自由现金流率ASURRIGL
| Q4 25 | — | — | ||
| Q3 25 | 15.6% | — | ||
| Q2 25 | 9.8% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | -13.2% | — |
资本支出强度ASURRIGL
| Q4 25 | — | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.8% | — |
现金转化率ASURRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASUR
| Recurring | $31.8M | 88% |
| Lathem Time | $4.6M | 13% |
RIGL
暂无分部数据
